GSK to fund startups through venture capital partnership

04/23/2013 | Wall Street Journal, The · Reuters

GlaxoSmithKline and Avalon Ventures, a venture capital firm, will fund up to 10 early-stage drug developers over the next three years. GSK will provide technical support and up to $465 million in initial funding and milestone payments, and will have first rights to buy each startup.

View Full Article in:

Wall Street Journal, The · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN